Journal Watch · Nature Communications · 2026
Switchable synthesis of aldehydes and alcohols by hydroformylation with ligand-modified Rh single-atom catalyst.
This work establishes ligand-modified single-atom catalysts as a versatile platform for controlling reaction chemoselectivity.
TL;DR
This work establishes ligand-modified single-atom catalysts as a versatile platform for controlling reaction chemoselectivity.
Key findings
- Characterizations and theoretical calculations reveal that the coordination of PPh<sub>3</sub> modulates the electronic structure of Rh, increasing the electron density at Rh centers.
- This electronic modification alters the hydrogenation pathway from oxygen-then-carbon to carbon-then-oxygen, raising the Gibbs free energy barrier for the rate-determining step of aldehyde hydrogenation by 0.26 eV, thereby switching the chemoselectivity to aldehyde.
- This work establishes ligand-modified single-atom catalysts as a versatile platform for controlling reaction chemoselectivity.
Numbers at a glance (from the abstract)
Every figure above is taken verbatim from the abstract below. Check the full text for denominators, confidence intervals and subgroup detail.
What they did
Herein, we report CeO<sub>2</sub>-supported single-atom Rh catalyst, in which triphenylphosphine (PPh<sub>3</sub>) serves as molecular switch to precisely modulate the chemoselectivity between alcohols and aldehydes in alkene hydroformylation with broad substrate compatibility and excellent stability. The Rh/CeO<sub>2</sub> exhibits up to 99% chemoselectivity and 93% yield toward alcohols, while the PPh<sub>3</sub>-Rh/CeO<sub>2</sub> shifts the chemoselectivity to aldehydes with up to 99% with 91% yield.
Full abstract (original)
Background: Controlling product selectivity in catalysis is fundamental for green synthesis, yet challenging, especially aiming for switchable outcomes between different products within a single catalytic system. This is exemplified in the industrially crucial hydroformylation reaction, where achieving controlled switching between aldehydes and alcohols remains difficult due to the inability of uniform active site to independently govern the hydrogenation and desorption steps of the aldehyde intermediate.
What they did: Herein, we report CeO<sub>2</sub>-supported single-atom Rh catalyst, in which triphenylphosphine (PPh<sub>3</sub>) serves as molecular switch to precisely modulate the chemoselectivity between alcohols and aldehydes in alkene hydroformylation with broad substrate compatibility and excellent stability. The Rh/CeO<sub>2</sub> exhibits up to 99% chemoselectivity and 93% yield toward alcohols, while the PPh<sub>3</sub>-Rh/CeO<sub>2</sub> shifts the chemoselectivity to aldehydes with up to 99% with 91% yield.
Results & conclusions: Characterizations and theoretical calculations reveal that the coordination of PPh<sub>3</sub> modulates the electronic structure of Rh, increasing the electron density at Rh centers. This electronic modification alters the hydrogenation pathway from oxygen-then-carbon to carbon-then-oxygen, raising the Gibbs free energy barrier for the rate-determining step of aldehyde hydrogenation by 0.26 eV, thereby switching the chemoselectivity to aldehyde. This work establishes ligand-modified single-atom catalysts as a versatile platform for controlling reaction chemoselectivity.
Abstract © the authors / Nature Communications (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.1038/s41467-026-73450-0 · PubMed 42192099.
Why it matters for pharma & biotech
- Relevant to General & Medicine teams tracking Nature Communications for new targets, mechanisms and biomarkers.
- As earlier-stage work, its near-term value is target validation and assay design rather than clinical decisions.
- For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.
Limitations & what to check in the full text
- This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.
Frequently asked questions
What did this Nature Communications study find?
This work establishes ligand-modified single-atom catalysts as a versatile platform for controlling reaction chemoselectivity.
What type of study is this?
It is a clinical study, published in Nature Communications in 2026. Herein, we report CeO<sub>2</sub>-supported single-atom Rh catalyst, in which triphenylphosphine (PPh<sub>3</sub>) serves as molecular switch to precisely modulate the chemoselectivity between alcohols and aldehydes in alkene hydroformylation with broad substrate compatibility and excellent stability.
Where can I read the original paper?
The original is at the publisher via DOI 10.1038/s41467-026-73450-0. PubMed ID: 42192099. BioStudioAI reproduces the abstract for discussion and links to the source.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/switchable-synthesis-of-aldehydes-and-alcohols-by-hydroformylation-with-734500/
Reading papers is step one. Analysing the data is the work.
BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.
Open BioStudioAI More guides